Stryker (LTS:0R2S) Cyclically Adjusted FCF per Share: $7.69 (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

LTS:0R2S Stryker Corp LTS:0R2S
88 GF Score
Price $273.41
GF Value $416.95
Valuation Significantly Undervalued
! 1 Warning Sign
View Full Analysis

What is Stryker Cyclically Adjusted FCF per Share?

Stryker LTS:0R2S +0.88% 88 Cyclically Adjusted FCF per Share is $7.69 as of Jun. 2026. GuruFocus rates LTS:0R2S with a GF Score™ of 88/100 and a GF Value™ of $416.95 (Significantly Undervalued). The stock has 1 warning sign investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Stryker's adjusted free cash flow per share for the three months ended in Jun. 2026 was $2.744. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is $7.69 for the trailing ten years ended in Jun. 2026.

During the past 12 months, Stryker's average Cyclically Adjusted FCF Growth Rate was 19.30% per year. During the past 3 years, the average Cyclically Adjusted FCF Growth Rate was 11.00% per year. During the past 5 years, the average Cyclically Adjusted FCF Growth Rate was 10.20% per year. During the past 10 years, the average Cyclically Adjusted FCF Growth Rate was 8.50% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of Stryker was 81.70% per year. The lowest was 3.90% per year. And the median was 11.90% per year.

As of today (2026-09-13), Stryker's current stock price is $273.405. Stryker's Cyclically Adjusted FCF per Share for the quarter that ended in Jun. 2026 was $7.69. Stryker's Cyclically Adjusted Price-to-FCF of today is 35.55.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Stryker was 64.82. The lowest was 32.55. And the median was 50.25.


Stryker  (LTS:0R2S) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Stryker's Cyclically Adjusted Price-to-FCF of today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/Cyclically Adjusted FCF per Share
=273.405/7.69
=35.55

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Stryker was 64.82. The lowest was 32.55. And the median was 50.25.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Stryker Cyclically Adjusted FCF per Share Related Terms


Stryker Cyclically Adjusted FCF per Share Historical Data

* Premium members only.

The historical data trend for Stryker's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Stryker Cyclically Adjusted FCF per Share Chart

Stryker Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 5.04 5.30 5.70 6.27 7.34

Stryker Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 6.43 7.07 7.34 7.44 7.69

LTS:0R2S vs MDT, BSX, ABT: Cyclically Adjusted FCF per Share Comparison

For the Medical Devices subindustry, Stryker's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Stryker Cyclically Adjusted Price-to-FCF vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Stryker's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Stryker's Cyclically Adjusted Price-to-FCF falls into.


LTS:0R2S
88GF Score
Stryker Corp LTS:0R2S
Cyclically Adjusted FCF per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Stryker Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Stryker's adjusted Free Cash Flow per Share data for the three months ended in Jun. 2026 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Jun. 2026 (Change)*Current CPI (Jun. 2026)
=2.744/333.9520*333.9520
=2.744

Current CPI (Jun. 2026) = 333.9520.

Stryker Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201609 1.013 241.428 1.401
201612 1.358 241.432 1.878
201703 0.032 243.801 0.044
201706 1.367 244.955 1.864
201709 -0.166 246.819 -0.225
201712 1.294 246.524 1.753
201803 0.462 249.554 0.618
201806 1.294 251.989 1.715
201809 1.257 252.439 1.663
201812 2.347 251.233 3.120
201903 0.504 254.202 0.662
201906 0.920 256.143 1.199
201909 1.225 256.759 1.593
201912 1.410 256.974 1.832
202003 1.177 258.115 1.523
202006 1.361 257.797 1.763
202009 1.999 260.280 2.565
202012 2.812 260.474 3.605
202103 0.967 264.877 1.219
202106 2.019 271.696 2.482
202109 2.098 274.310 2.554
202112 2.077 278.802 2.488
202203 0.219 287.504 0.254
202206 1.010 296.311 1.138
202209 1.967 296.808 2.213
202212 2.132 296.797 2.399
202303 0.822 301.836 0.909
202306 1.396 305.109 1.528
202309 2.349 307.789 2.549
202312 3.604 306.746 3.924
202403 0.096 312.332 0.103
202406 1.248 314.175 1.327
202409 3.382 315.301 3.582
202412 4.311 315.605 4.562
202503 0.329 319.799 0.344
202506 2.402 322.561 2.487
202509 3.499 324.800 3.598
202512 4.851 324.054 4.999
202603 1.074 330.213 1.086
202606 2.744 333.952 2.744

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

What does a Cyclically Adjusted FCF per Share of $7.69 mean?
Stryker (LTS:0R2S) has a Cyclically Adjusted FCF per Share of $7.69 as of Jun. 2026. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Stryker and its competitors.
Is Stryker's Cyclically Adjusted FCF per Share too high?
Stryker's current Cyclically Adjusted FCF per Share is $7.69. Overall, Stryker has a GF Score™ of 88/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Stryker's Cyclically Adjusted FCF per Share compare to MDT and BSX?
Stryker's Cyclically Adjusted FCF per Share of $7.69 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted FCF per Share for a Medical Devices & Instruments company?
A good Cyclically Adjusted FCF per Share depends on the Medical Devices & Instruments industry context. However, Cyclically Adjusted FCF per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted FCF per Share mean?
A high Cyclically Adjusted FCF per Share can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on Stryker and its competitors. Stryker's current Cyclically Adjusted FCF per Share is $7.69. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Stryker stock overvalued right now?
Based on GuruFocus' analysis, Stryker (LTS:0R2S) is currently considered Significantly Undervalued. The stock's GF Value™ is $416.95, compared to a current price of $273.41 — trading 34.4% below its estimated fair value. The current Cyclically Adjusted FCF per Share is $7.69. Stryker's overall GF Score™ is 88/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted FCF per Share calculated?
Cyclically Adjusted FCF per Share is calculated from a company's financial statements. For Stryker (LTS:0R2S), the current Cyclically Adjusted FCF per Share is $7.69 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Stryker (LTS:0R2S) Overvalued in 2026?

Based on GuruFocus' analysis, Stryker stock appears to be undervalued. The current stock price of $273.41 is trading 34.4% below its estimated GF Value™ of $416.95. GuruFocus considers Stryker to be Significantly Undervalued.

Key valuation signals for LTS:0R2S:

  • Cyclically Adjusted FCF per Share: $7.69
  • GF Value™: $416.95 vs. price of $273.41 (34.4% below fair value)
  • GF Score™: 88/100 with 1 warning sign

No single metric tells the full story. See the LTS:0R2S stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Stryker Business Description

Address 1941 Stryker Way, Portage, MI, USA, 49002
Stryker designs, manufactures, and markets an array of medical equipment, instruments, consumable supplies, and implantable devices. The product portfolio includes hip and knee replacements, extremities, endoscopy systems, operating room equipment, embolic coils, hospital beds and gurneys, and orthopedic robotics. Stryker remains one of the three largest competitors in reconstructive orthopedic implants and holds the leadership position in operating room equipment. Roughly one-fourth of Stryker's total revenue currently comes from outside the United States.
88GF Score

Get the complete analysis for LTS:0R2S

Cyclically Adjusted FCF per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$273.41
Price
$416.95
GF Value